JPRN-jRCT1080223804已完成4 期
A Prospective, Multicenter, Observational Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated with Ixazomib plus Lenalidomide and Dexamethasone
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 295
研究概览
简要总结
The results of this study have shown that IRd therapy is an effective and well-tolerated treatment option as well under conditions outside of clinical trials.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Men and women aged 20 years or older at the time of enrollment
- •2.Patients with RRMM
- •3.Participants who are scheduled to start IRd therapy
- •4.Participants who can provide written informed consent of their own free will before the start of study treatment
- •5.Participants who are judged by the principal investigator or investigator(s) to have the faculty to understand and comply with the requirements of the study
排除标准
- •1.Female participants who are nursing or pregnant
- •2.Participants who have been treated with ixazomib
- •3.Participants with hypersensitivity to any of the components of IRd therapy, their analogs or excipients
- •4.Participants with another active malignancy, i.e. synchronous active malignancy or previous malignancy with a disease-free period of less than 5 years, except for patients with carcinoma in situ (intraepithelial carcinoma) or intramucosal carcinoma judged to be cured by topical treatment
- •5.Participants who are not registered with, or comply with, the guidelines of the lenalidomide management program
- •6.Participants who, in the judgement of the principal investigator or investigator(s), are considered to be unsuitable for enrolment into the study
研究者
相似试验
已完成
不适用
An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 InfectionHIV InfectionsNCT01902615Hoffmann-La Roche58
终止
3 期
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) EventsElevated High-sensitivity C-Reactive Protein (hsCRP)NCT00239681AstraZeneca17,802
Unknown
不适用
Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin LymphomaImmune Checkpoint InhibitorRadiotherapyHodgkin LymphomaNCT04419441Ospedale Maggiore Di Trieste12
已完成
2 期
Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.Breast CancerNCT00287534AstraZeneca1,059
Unknown
不适用
Rotablation vs Intravascular Lithotripsy in Calcified Coronary LesionsCalcificationCoronary Artery DiseaseNCT04960319Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.100